Skip to main content
See every side of every news story
Published loading...Updated

First ALS Reversal Reported Using Brain Temperature Therapy

A 56-year-old woman with progressive ALS regained motor and cognitive functions after AI-guided brain temperature therapy, with no adverse effects reported in 11 months, researchers say.

  • MIAMI, Dec. 04, 2025, BTT Medical Institute and btt Corp. announced the first documented total reversal of ALS using Computerized Brain‑Guided Intelligent Thermofebrile Therapy, reported in Diseases.
  • Developed from the Brain‑Eyelid Thermoregulatory Tunnel, CBIT2 digitally reengineers fever therapy to activate heat shock proteins and clear misfolded TDP‑43 in ALS.
  • Electromyography showed complete reversal of denervation, molecular biomarkers IL‑10 and NfL improved after two CBIT2 sessions, and cognitive and functional measures rose in Moira Papp.
  • BTT Medical Institute said it will start formal clinical trials in early 2026 to test safety and reproducibility, while the report states Moira Papp no longer meets ALS criteria and stopped ALS medications.
  • Amid a global brain‑health crisis, neurological disorders affect over three billion people worldwide, and Alzheimer's cost the U.S. $360 billion in 2024, framing a critical unmet need, Dr. M. Marc Abreu said this is "a paradigm shift" with potential for Alzheimer's, Parkinson's and related disorders.
Insights by Ground AI

7 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Globe Newswire broke the news in on Thursday, December 4, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal